Live from the NIH registry
Studies recruiting near Bakersfield right now
Top 25 of 72 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: ViiV Healthcare
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Bladder Cancer, Urinary Bladder Neoplasms
Phase 1, Phase 2
Interventional 45 participants sought
Michael G Oefelein Clinical Trials ( Site 0005) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
Stargardt Disease
Phase 1, Phase 2
Interventional 18 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: Ray Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
National Institute of Clinical Research — Bakersfield, California (1.7 mi)
· Sponsor: CSL Behring
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Chronic Spontaneous Urticaria
Phase 2
Interventional 200 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Pfizer
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Retinitis Pigmentosa
Phase 2
Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: jCyte, Inc
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
California Retina Consultants (CRC) - Bakersfield Office — Bakersfield, California (1.7 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 981 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: GlaxoSmithKline
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
Dysphotopsia, Posterior Capsule Opacification
N/A
Observational 120 participants sought
Empire Eye and Laser Center — Bakersfield, California (1.7 mi)
· Sponsor: Dr. Daniel H. Chang, MD
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Phase 3
Interventional 1,100 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Pfizer
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Diabetic Macular Edema (DME)
Phase 2
Interventional 180 participants sought
Site 104 — Bakersfield, California (1.7 mi)
· Sponsor: BioAge Labs, Inc.
A Study in Adults With Geographic Atrophy
Geographic Atrophy
Phase 2
Interventional 300 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: Sitala Bio LTD
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
Phase 3
Interventional 138 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: GlaxoSmithKline
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Phase 3
Interventional 500 participants sought
CBCC Global Research - Comprehensive Blood & Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Phase 2
Interventional 15 participants sought
Adverum site 109 — Bakersfield, California (1.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Kern Allergy and Medical Research- Site Number : 8400016 — Bakersfield, California (1.7 mi)
· Sponsor: Sanofi
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
AMD, nAMD
Phase 3
Interventional 714 participants sought
California Retina Consultants - Bakersfield /ID# 256240 — Bakersfield, California (1.7 mi)
· Sponsor: AbbVie
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Benign Prostatic Hyperplasia
N/A
Interventional 215 participants sought
Michael G Oefelein Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Rivermark Medical
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
National Institute of Clinical Research - Bakersfield — Bakersfield, California (1.7 mi)
· Sponsor: Pfizer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology